Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.

Ítems similars

• Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.
  per: Pleskoff, O, et al.
  Publicat: (1995)
• Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.
  per: Labrosse, B, et al.
  Publicat: (1997)
• Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
  per: Saint-Julien, L, et al.
  Publicat: (1992)
• Effects of MS-8209, an Amphotericin B Derivative, on Tumor Necrosis Factor Alpha Synthesis and Human Immunodeficiency Virus Replication in Macrophages
  per: Clayette, Pascal, et al.
  Publicat: (2000)
• MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.
  per: Adjou, K T, et al.
  Publicat: (1995)